![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
GR Breese, A Baumeister, TC Napier, GD Frye and RA Mueller
The present investigation supports the hypothesis that functionally supersensitive D-1 dopamine receptors are involved in the self- mutilation behavior (SMB) induced by L-dihydroxyphenylalanine (L-dopa) in rats treated neonatally with 6-hydroxydopamine (6-OHDA). This conclusion is based upon 1) the antagonism of this behavior by SCH- 23390, a D-1 antagonist; 2) induction of SMB in neonatal-6-OHDA-treated rats by the D-1 agonist, SKF-38393; 3) the high correlation of the supersensitive locomotor responses to the D-1 agonist with the occurrence of L-dopa-induced SMB; and 4) the inability of the D-2 agonist, LY-171555, to induce SMB in rats treated neonatally with 6- OHDA. The specificity of SCH-23390 and SKF-38393 for the D-1 dopamine receptor was supported by the absence of action of SCH-23390 against locomotor activities induced by LY-171555 and its blockade of SKF-38393- induced locomotion in 6-OHDA-treated rats. Behavioral responses to D-1 and D-2 agonists did not show the same profile in adult and neonatally 6-OHDA-treated rats, providing further support for the view that the age at which dopaminergic neurons are destroyed has differing effects on motor output. Many of the behaviors observed when the D-2 dopamine receptor was activated by LY-171555 were apparent after SKF-38393 in neonatally 6-OHDA-treated rats. Similar behavioral responses to the D-1 and D-2 agonists were also observed in adult 6-OHDA-treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  S. T. Papadeas, B. L. Blake, D. J. Knapp, and G. R. Breese Sustained Extracellular Signal-Regulated Kinase 1/2 Phosphorylation in Neonate 6-Hydroxydopamine-Lesioned Rats after Repeated D1-Dopamine Receptor Agonist Administration: Implications for NMDA Receptor Involvement J. Neurosci., June 30, 2004; 24(26): 5863 - 5876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Yokoyama and H. Okamura Self-Injurious Behavior and Dopaminergic Neuron System in Neonatal 6-Hydroxydopamine-Lesioned Rat: 1. Dopaminergic Neurons and Receptors J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1016 - 1030. [Abstract] [Full Text]
|
|
|
|
|
|
H. Okamura, T. Murakami, C. Yokoyama, T. Nakamura, and Y. Ibata Self-Injurious Behavior and Dopaminergic Neuron System in Neonatal 6-Hydroxydopamine-Lesioned Rat: 2. Intracerebral Microinjection of Dopamine Agonists and Antagonists J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1031 - 1037. [Abstract] [Full Text]
|
|
|
|
|
|
N. Laprade, F. Radja, T. A. Reader, and J.-J. Soghomonian Dopamine Receptor Agonists Regulate Levels of the Serotonin 5-HT2A Receptor and its mRNA in a Subpopulation of Rat Striatal Neurons J. Neurosci., June 1, 1996; 16(11): 3727 - 3736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Naidu, C. A. Kitt, D. F. Wong, D. L. Price, J. C. Troncoso, and H. W. Moser Research on Rett Syndrome: Strategy and Preliminar Results J Child Neurol, January 1, 1988; 3(1_suppl): S78 - S86. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
